Blueprint Medicines - Funding, Financials, Valuation, Investors - Cointime

Bitcoin $61,234.02 +4.39%
Ethereum $1,646.03 +4.68%
BNB $558.22 +2.91%
Optimism $0.10 +4.24%
Arbitrum $0.08 +0.82%
Solana $82.42 +9.90%
Polygon $0.22 +2.77%
Cosmos $1.55 +3.04%
Avalanche $6.78 +2.02%

Bitcoin $61,234.02 +4.39%
Ethereum $1,646.03 +4.68%
BNB $558.22 +2.91%
Optimism $0.10 +4.24%
Arbitrum $0.08 +0.82%
Solana $82.42 +9.90%
Polygon $0.22 +2.77%
Cosmos $1.55 +3.04%
Avalanche $6.78 +2.02%

Blueprint Medicines

company

Investors

Number of Lead Investors

Number of Investors

4

15

Blueprint Medicines is funded by 15 investors. Partner Fund Management and Eight Roads Ventures are the most recent investors.

Investor Name	Lead Investor	Funding Round
Partner Fund Management	Yes	Series C
Eight Roads Ventures	Yes	Series Unknown
Casdin Capital	-	Series C
Cowen Group	-	Series C
Fidelity Biosciences	-	Series C
Nextech Invest	-	Series C
Perceptive Advisors	-	Series C
RA Capital Management	-	Series C
Redmile Group	-	Series C
Sabby Capital	-	Series C
Tavistock Life Sciences	-	Series C
Third Rock Ventures	-	Series C
Wellington Management	-	Series C
Biotechnology Value Fund	-	Series B
F-Prime Capital	-	Series B